SURGERY PARTNERS INC (SGRY)
US86881A1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to SGRY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.21. This target is 74.52% above the current price.
SGRY was analyzed by 17 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SGRY.
In the previous month the buy percentage consensus was at a similar level.
SGRY was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-06 | Barclays | Initiate | Equal-Weight |
| 2024-03-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-29 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-27 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-27 | Citigroup | Maintains | Buy -> Buy |
| 2023-11-14 | TD Cowen | Upgrade | Market Perform -> Outperform |
| 2023-10-12 | Benchmark | Reiterate | Buy -> Buy |
| 2023-09-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-02 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-07-31 | Benchmark | Reiterate | Buy -> Buy |
| 2023-07-11 | Mizuho | Maintains | Buy -> Buy |
| 2023-06-02 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-05-12 | Mizuho | Initiate | Buy |
| 2023-05-02 | RBC Capital | Reiterate | Outperform |
| 2023-05-02 | Benchmark | Reiterate | Buy |
| 2023-05-02 | Citigroup | Maintains | Buy |
| 2023-04-21 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-03-06 | Benchmark | Reiterate | Buy |
| 2023-03-02 | JP Morgan | Maintains | Neutral |
| 2023-01-18 | Barclays | Maintains | Overweight |
| 2022-12-05 | Benchmark | Maintains | Buy |
| 2022-11-23 | RBC Capital | Maintains | Outperform |
| 2022-11-22 | SVB Leerink | Maintains | Outperform |
| 2022-11-10 | RBC Capital | Maintains | Outperform |
| 2022-11-10 | SVB Leerink | Maintains | Outperform |
| 2022-11-09 | Citigroup | Maintains | Buy |
| 2022-08-03 | RBC Capital | Maintains | Outperform |
| 2022-06-15 | B of A Securities | Downgrade | Buy -> Neutral |